EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oral Bioinspired Peroxisome‐Engineered Probiotics for Modulating Gut Microbiota Homeostasis and Alleviating Cardiac Chemotherapy Toxicity

Shuyu Wang iD, Xiaowan Fan iD, Chao Zhang, Shuai Han, Yike Guo, Yuchen Wang, Wei Wang, Junyue Xing, Ying Liu, Wei Jiang iD, Xiaoying Chen

Advanced Science · 2026-07 · 13 (37)

DOI: 10.1002/advs.202519344 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 08.05.2026. Verfasst von Shuyu Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Cardiovascular Institute of Zhengzhou University, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Probiotics, Cardiotoxicity, Doxorubicin, Gastrointestinal Microbiome. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Henan Provincial Joint Fund of Science and Technology Research and Development Program, Health Science and Technology InnovationProgram of Henan Province for Excellent Young Scholars.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anthracyclines such as doxorubicin (DOX) are widely used in cancer chemotherapy but their clinical utility is severely limited by cumulative, dose‐dependent, and largely irreversible cardiotoxicity. Mounting evidence suggests that DOX disrupts intestinal barrier integrity and microbial homeostasis, aggravating systemic oxidative stress and accelerating myocardial injury through the gut–heart axis. Probiotics offer a potential strategy to stabilize the intestinal microenvironment, yet their fragile nature and poor survival in the gastrointestinal tract hinder clinical translation. Here, we present an orally administrable bioinspired peroxisome engineered probiotic (BPEP) as a safe and effective therapeutic platform. Ruthenium‐based nanozymes with superoxide dismutase‐like and catalase‐like activities were encapsulated in a lipid shell to form bioinspired peroxisomes (BP) and covalently anchored onto Escherichia coli Nissle 1917 . The lipid shell enhances probiotic resistance to gastric acid, bile salts, and reactive oxygen species, improving gastrointestinal survival and colonization. Acting as a living carrier, probiotics deliver BPs to the intestinal barrier, where they synergistically scavenge reactive oxygen and nitrogen species, restore tight junction integrity, and remodel microbial communities. In a chronic DOX‐induced cardiotoxicity mouse model, oral administration of BPEP effectively alleviated oxidative stress, preserved intestinal barrier function, stabilized microbial homeostasis, and ultimately improved cardiac function. This work establishes a bioinspired probiotic‐nanozyme hybrid strategy that overcomes the intrinsic limitations of natural probiotics and provides a promising approach for mitigating chemotherapy‐related cardiotoxicity via the gut‐heart axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsCardiotoxicityDoxorubicinGastrointestinal MicrobiomeAnimalsMiceHomeostasisAdministration, OralOxidative StressDisease Models, AnimalIntestinal Barrier FunctionMaleHumans

Stichwörter der Autor:innen

doxorubicin‐induced cardiotoxicitygut‐heart axisnanozymeoral targeted therapyprobiotics

Substanzen

Doxorubicin

Autor:innen und Institutionen

  • Department of Cardiology, Cardiovascular Institute of Zhengzhou University, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • National Health Commission Key Laboratory of Cardiovascular Regenerative Medicine, Central China Subcenter of National Center For Cardiovascular Diseases, Henan Cardiovascular Disease Center, Fuwai Central-China Cardiov…
  • School of Medicine of Henan University, Zhengzhou, Henan, China.
  • Nanozyme Laboratory in Zhongyuan, Henan Academy of Innovations in Medical Science, Zhengzhou, Henan, China.
  • State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China.
  • Institute of Cardiovascular Disease, Henan Academy of Innovations in Medical Science, Zhengzhou, Henan, China.

ORCID-Profile: Shuyu Wang, Xiaowan Fan, Wei Jiang

Förderung

  • National Natural Science Foundation of China
  • Henan Provincial Joint Fund of Science and Technology Research and Development Program
  • Health Science and Technology InnovationProgram of Henan Province for Excellent Young Scholars
  • Independent Research Project of the Central China Subcenter of National Center for Cardiovascular Diseases

Zitieren

APA

Wang, S., Fan, X., Zhang, C., Han, S., Guo, Y., Wang, Y., Wang, W., Xing, J., Liu, Y., Jiang, W., & Chen, X. (2026). Oral Bioinspired Peroxisome‐Engineered Probiotics for Modulating Gut Microbiota Homeostasis and Alleviating Cardiac Chemotherapy Toxicity. Advanced Science, 13(37). https://doi.org/10.1002/advs.202519344

Vancouver

Wang S, Fan X, Zhang C, Han S, Guo Y, Wang Y, et al. Oral Bioinspired Peroxisome‐Engineered Probiotics for Modulating Gut Microbiota Homeostasis and Alleviating Cardiac Chemotherapy Toxicity. Advanced Science. 2026;13(37). doi:10.1002/advs.202519344

BibTeX
@article{Wang2026,
  author = {Wang, Shuyu and Fan, Xiaowan and Zhang, Chao and Han, Shuai and Guo, Yike and Wang, Yuchen and Wang, Wei and Xing, Junyue and Liu, Ying and Jiang, Wei and Chen, Xiaoying},
  title = {Oral Bioinspired Peroxisome‐Engineered Probiotics for Modulating Gut Microbiota Homeostasis and Alleviating Cardiac Chemotherapy Toxicity},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {37},
  doi = {10.1002/advs.202519344}
}
Kostenlos starten →